Yin, Wenqin https://orcid.org/0000-0003-3892-5108
Luo, Dan
Mi, Haiqi
Ren, Zhimin
Li, Lianling
Fan, Zhidong
Lin, Jingyan
Article History
Accepted: 29 April 2025
First Online: 22 May 2025
Declarations
:
: Jingyan Lin has received a grant from Jiangsu Hengrui Pharmaceutical, China, for a study on liposomal bupivacaine. Wenqin Yin, Dan Luo, Haiqi Mi, Zhimin Ren, Lianling Li, and Zhidong Fan declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. None of the authors was involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Not applicable for this review.
: Not applicable for this review.
: Not applicable.
: All authors have contributed to the conception of the work. All authors wrote the original draft and performed substantial contributions to the final manuscript. All authors reviewed and approved the final manuscript for submission. All authors agreed to be accountable for all aspects of the work.
: No funding was obtained for the preparation of this article.
: Not applicable for this review.
: Not applicable.